Correlation Between Akari Therapeutics and Vyne Therapeutics
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and Vyne Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and Vyne Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and Vyne Therapeutics, you can compare the effects of market volatilities on Akari Therapeutics and Vyne Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of Vyne Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and Vyne Therapeutics.
Diversification Opportunities for Akari Therapeutics and Vyne Therapeutics
-0.77 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Akari and Vyne is -0.77. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and Vyne Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vyne Therapeutics and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with Vyne Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vyne Therapeutics has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and Vyne Therapeutics go up and down completely randomly.
Pair Corralation between Akari Therapeutics and Vyne Therapeutics
Given the investment horizon of 90 days Akari Therapeutics PLC is expected to under-perform the Vyne Therapeutics. In addition to that, Akari Therapeutics is 1.78 times more volatile than Vyne Therapeutics. It trades about -0.22 of its total potential returns per unit of risk. Vyne Therapeutics is currently generating about 0.19 per unit of volatility. If you would invest 237.00 in Vyne Therapeutics on August 24, 2024 and sell it today you would earn a total of 53.00 from holding Vyne Therapeutics or generate 22.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Akari Therapeutics PLC vs. Vyne Therapeutics
Performance |
| Timeline |
| Akari Therapeutics PLC |
| Vyne Therapeutics |
Akari Therapeutics and Vyne Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Akari Therapeutics and Vyne Therapeutics
The main advantage of trading using opposite Akari Therapeutics and Vyne Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, Vyne Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vyne Therapeutics will offset losses from the drop in Vyne Therapeutics' long position.| Akari Therapeutics vs. Lyra Therapeutics | Akari Therapeutics vs. Hookipa Pharma | Akari Therapeutics vs. Cingulate Warrants | Akari Therapeutics vs. SAB Biotherapeutics |
| Vyne Therapeutics vs. Akari Therapeutics PLC | Vyne Therapeutics vs. Salarius Pharmaceuticals | Vyne Therapeutics vs. Histogen | Vyne Therapeutics vs. SAB Biotherapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |